|
1
|
National Center for Injury Prevention and
Control: WISQARS Leading Causes of Death Reports. 1999–2006.
|
|
2
|
Coady MA, Rizzo JA, Goldstein LJ and
Elefteriades JA: Natural history, pathogenesis, and etiology of
thoracic aortic aneurysms and dissections. Cardiol Clin.
17:615–635. vii:1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Hamamsy I and Yacoub MH: Cellular and
molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol.
6:771–786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barbour JR, Spinale FG and Ikonomidis JS:
Proteinase systems and thoracic aortic aneurysm progression. J Surg
Res. 139:292–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikonomidis JS, Jones JA, Barbour JR,
Stroud RE, Clark LL, Kaplan BS, Zeeshan A, Bavaria JE, Gorman JH
III, Spinale FG and Gorman RC: Expression of matrix
metalloproteinases and endogenous inhibitors within ascending
aortic aneurysms of patients with bicuspid or tricuspid aortic
valves. J Thorac Cardiovasc Surg. 133:1028–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He R, Guo DC, Sun W, Papke CL, Duraisamy
S, Estrera AL, Safi HJ, Ahn C, Buja LM, Arnett FC, et al:
Characterization of the inflammatory cells in ascending thoracic
aortic aneurysms in patients with Marfan syndrome, familial
thoracic aortic aneurysms, and sporadic aneurysms. J Thorac
Cardiovasc Surg. 136:922–929, 929.e1. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Shen YH and LeMaire SA: Thoracic
aortic dissection: Are matrix metalloproteinases involved?
Vascular. 17:147–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones JA, Barbour JR, Lowry AS, Bouges S,
Beck C, McClister DM Jr, Mukherjee R and Ikonomidis JS:
Spatiotemporal expression and localization of matrix
metalloproteinas-9 in a murine model of thoracic aortic aneurysm. J
Vasc Surg. 44:1314–1321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao J, Geng L, Wu Q, Wang W, Chen Q, Lu L,
Shen W and Chen Y: Spatiotemporal expression of matrix
metalloproteinases (MMPs) is regulated by the
Ca2+-signal transducer S100A4 in the pathogenesis of
thoracic aortic aneurysm. PLoS One. 8:e700572013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin KA, Merenick BL, Ding M, Fetalvero
KM, Rzucidlo EM, Kozul CD, Brown DJ, Chiu HY, Shyu M, Drapeau BL,
et al: Rapamycin promotes vascular smooth muscle cell
differentiation through insulin receptor
substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
J Biol Chem. 282:36112–36120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao J, Gong L, Guo DC, Mietzsch U, Kuang
SQ, Kwartler CS, Safi H, Estrera A, Gambello MJ and Milewicz DM:
Thoracic aortic disease in tuberous sclerosis complex: Molecular
pathogenesis and potential therapies in Tsc2+/− mice.
Hum Mol Genet. 19:1908–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geng L, Wang W, Chen Y, Cao J, Lu L, Chen
Q, He R and Shen W: Elevation of ADAM10, ADAM17, MMP-2 and MMP-9
expression with media degeneration features
CaCl2-induced thoracic aortic aneurysm in a rat model.
Exp Mol Pathol. 89:72–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo DC, Pannu H, Tran-Fadulu V, Papke CL,
Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, et al:
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic
aortic aneurysms and dissections. Nat Genet. 39:1488–1493. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dodd T, Jadhav R, Wiggins L, Stewart J,
Smith E, Russell JC and Rocic P: MMPs 2 and 9 are essential for
coronary collateral growth and are prominently regulated by p38
MAPK. J Mol Cell Cardiol. 51:1015–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dabek J, Glogowska-Ligus J and Szadorska
B: Transcription activity of MMP-2 and MMP-9 metalloproteinase
genes and their tissue inhibitor (TIMP-2) in acute coronary
syndrome patients. J Postgrad Med. 59:115–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huusko T, Salonurmi T, Taskinen P,
Liinamaa J, Juvonen T, Pääkkö P, Savolainen M and Kakko S: Elevated
messenger RNA expression and plasma protein levels of osteopontin
and matrix metalloproteinase types 2 and 9 in patients with
ascending aortic aneurysms. J Thorac Cardiovasc Surg.
145:1117–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nordon IM, Hinchliffe RJ, Loftus IM and
Thompson MM: Pathophysiology and epidemiology of abdominal aortic
aneurysms. Nat Rev Cardiol. 8:92–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Erdheim J: Medionecrosis aortae
idiopathica cystica. Virchows Arch (Pathol Anat). 276:187–229.
1930. View Article : Google Scholar
|
|
19
|
Girardi LN and Coselli JS: Inflammatory
aneurysm of the ascending aorta and aortic arch. Ann Thorac Surg.
64:251–253. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Biddinger A, Rocklin M, Coselli J and
Milewicz DM: Familial thoracic aortic dilatations and dissections:
A case control study. J Vasc Surg. 25:506–511. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roth M, Lemke P, Bohle RM, Klovekorn WP
and Bauer EP: Inflammatory aneurysm of the ascending thoracic
aorta. J Thorac Cardiovasc Surg. 123:822–824. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He R, Guo DC, Estrera AL, Safi HJ, Huynh
TT, Yin Z, Cao SN, Lin J, Kurian T, Buja LM, et al:
Characterization of the inflammatory and apoptotic cells in the
aortas of patients with ascending thoracic aortic aneurysms and
dissections. J Thorac Cardiovasc Surg. 131:671–678. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang PC, Yakimov AO, Teesdale MA, Coady
MA, Dardik A, Elefteriades JA and Tellides G: Transmural
inflammation by interferon-gamma-producing T cells correlates with
outward vascular remodeling and intimal expansion of ascending
thoracic aortic aneurysms. FASEB J. 19:1528–1530. 2005.PubMed/NCBI
|
|
24
|
Shepherd J and Nicklin MJ: Elastic-vessel
arteritis in interleukin-1 receptor antagonist-deficient mice
involves effector Th1 cells and requires interleukin-1 receptor.
Circulation. 111:3135–3140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davis VA, Persidskaia RN, Baca-Regen LM,
Fiotti N, Halloran BG and Baxter BT: Cytokine pattern in aneurysmal
and occlusive disease of the aorta. J Surg Res. 101:152–156. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jones KG, Brull DJ, Brown LC, Sian M,
Greenhalgh RM, Humphries SE and Powell JT: Interleukin-6 (IL-6) and
the prognosis of abdominal aortic aneurysms. Circulation.
103:2260–2265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schönbeck U, Sukhova GK, Gerdes N and
Libby P: T(H)2 predominant immune responses prevail in human
abdominal aortic aneurysm. Am J Pathol. 161:499–506. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walton LJ, Franklin IJ, Bayston T, Brown
LC, Greenhalgh RM, Taylor GW and Powell JT: Inhibition of
prostaglandin E2 synthesis in abdominal aortic aneurysms:
Implications for smooth muscle cell viability, inflammatory
processes, and the expansion of abdominal aortic aneurysms.
Circulation. 100:48–54. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnston WF, Salmon M, Pope NH, Meher A,
Su G, Stone ML, Lu G, Owens GK, Upchurch GR Jr and Ailawadi G:
Inhibition of interleukin-1β decreases aneurysm formation and
progression in a novel model of thoracic aortic aneurysms.
Circulation. 130 11 Suppl 1:51–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lesauskaite V, Epistolato MC, Castagnini
M, Urbonavicius S and Tanganelli P: Expression of matrix
metalloproteinases, their tissue inhibitors, and osteopontin in the
wall of thoracic and abdominal aortas with dilatative pathology.
Hum Pathol. 37:1076–1084. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: A small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Senolt L, Grigorian M, Lukanidin E, Simmen
B, Michel BA, Pavelka K, Gay RE, Gay S and Neidhart M: S100A4 is
expressed at site of invasion in rheumatoid arthritis synovium and
modulates production of matrix metalloproteinases. Ann Rheum Dis.
65:1645–1648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oslejsková L, Grigorian M, Gay S, Neidhart
M and Senolt L: The metastasis associated protein S100A4: A
potential novel link to inflammation and consequent aggressive
behaviour of rheumatoid arthritis synovial fibroblasts. Ann Rheum
Dis. 67:1499–1504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martin KA, Rzucidlo EM, Merenick BL,
Fingar DC, Brown DJ, Wagner RJ and Powell RJ: The mTOR/p70 S6K1
pathway regulates vascular smooth muscle cell differentiation. Am J
Physiol Cell Physiol. 286:C507–C517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Holmes DR Jr, Leon MB, Moses JW, Popma JJ,
Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, et
al: Analysis of 1-year clinical outcomes in the SIRIUS trial: a
randomized trial of a sirolimus-eluting stent versus a standard
stent in patients at high risk for coronary restenosis.
Circulation. 109:634–640. 2004. View Article : Google Scholar : PubMed/NCBI
|
